Clinical Trial Update: The Role of Microparticles as a Biomarker

View source ↗

Summary

A University of Rochester trial evaluating microparticles as a biomarker for atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome
• Thrombotic Thrombocytopenic Purpura

Snippet

Sponsor: University of Rochester | Conditions: Atypical Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura | Status: WITHDRAWN